A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.
暂无分享，去创建一个
G. Parmiani | C. Castelli | L. Rivoltini | F. Belli | A. Mazzocchi | F. Rini | P. Squarcina | D. Loftus | P. Tarsini | V. Viggiano | G. Parmiani | Filiberto Belli | Vincenzo Viggiano